vs

Side-by-side financial comparison of UNIVERSAL TECHNICAL INSTITUTE INC (UTI) and Xometry, Inc. (XMTR). Click either name above to swap in a different company.

UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $192.4M, roughly 1.1× Xometry, Inc.). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 5.8% vs -4.5%, a 10.3% gap on every dollar of revenue. On growth, Xometry, Inc. posted the faster year-over-year revenue change (29.5% vs 9.6%). Xometry, Inc. produced more free cash flow last quarter ($-5.9M vs $-19.2M). Over the past eight quarters, Xometry, Inc.'s revenue compounded faster (25.2% CAGR vs 9.5%).

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

Xometry is an online marketplace for sourcing on-demand manufactured parts for prototyping and large-scale production.

UTI vs XMTR — Head-to-Head

Bigger by revenue
UTI
UTI
1.1× larger
UTI
$220.8M
$192.4M
XMTR
Growing faster (revenue YoY)
XMTR
XMTR
+19.9% gap
XMTR
29.5%
9.6%
UTI
Higher net margin
UTI
UTI
10.3% more per $
UTI
5.8%
-4.5%
XMTR
More free cash flow
XMTR
XMTR
$13.3M more FCF
XMTR
$-5.9M
$-19.2M
UTI
Faster 2-yr revenue CAGR
XMTR
XMTR
Annualised
XMTR
25.2%
9.5%
UTI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
UTI
UTI
XMTR
XMTR
Revenue
$220.8M
$192.4M
Net Profit
$12.8M
$-8.6M
Gross Margin
39.1%
Operating Margin
7.1%
-4.6%
Net Margin
5.8%
-4.5%
Revenue YoY
9.6%
29.5%
Net Profit YoY
-42.1%
12.7%
EPS (diluted)
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
UTI
UTI
XMTR
XMTR
Q4 25
$220.8M
$192.4M
Q3 25
$222.4M
$180.7M
Q2 25
$204.3M
$162.5M
Q1 25
$207.4M
$151.0M
Q4 24
$201.4M
$148.5M
Q3 24
$196.4M
$141.7M
Q2 24
$177.5M
$132.6M
Q1 24
$184.2M
$122.7M
Net Profit
UTI
UTI
XMTR
XMTR
Q4 25
$12.8M
$-8.6M
Q3 25
$18.8M
$-11.6M
Q2 25
$10.7M
$-26.4M
Q1 25
$11.4M
$-15.1M
Q4 24
$22.2M
$-9.9M
Q3 24
$18.8M
$-10.2M
Q2 24
$5.0M
$-13.7M
Q1 24
$7.8M
$-16.6M
Gross Margin
UTI
UTI
XMTR
XMTR
Q4 25
39.1%
Q3 25
39.9%
Q2 25
40.1%
Q1 25
37.3%
Q4 24
39.7%
Q3 24
39.4%
Q2 24
39.9%
Q1 24
39.0%
Operating Margin
UTI
UTI
XMTR
XMTR
Q4 25
7.1%
-4.6%
Q3 25
11.2%
-6.1%
Q2 25
6.9%
-6.3%
Q1 25
8.1%
-10.2%
Q4 24
13.6%
-7.8%
Q3 24
13.3%
-8.1%
Q2 24
4.2%
-11.5%
Q1 24
6.1%
-14.6%
Net Margin
UTI
UTI
XMTR
XMTR
Q4 25
5.8%
-4.5%
Q3 25
8.4%
-6.4%
Q2 25
5.2%
-16.3%
Q1 25
5.5%
-10.0%
Q4 24
11.0%
-6.7%
Q3 24
9.6%
-7.2%
Q2 24
2.8%
-10.3%
Q1 24
4.2%
-13.5%
EPS (diluted)
UTI
UTI
XMTR
XMTR
Q4 25
$0.23
Q3 25
$0.33
Q2 25
$0.19
Q1 25
$0.21
Q4 24
$0.40
Q3 24
$0.35
Q2 24
$0.09
Q1 24
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
UTI
UTI
XMTR
XMTR
Cash + ST InvestmentsLiquidity on hand
$162.8M
$219.1M
Total DebtLower is stronger
$101.4M
Stockholders' EquityBook value
$335.9M
$275.6M
Total Assets
$834.0M
$703.7M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
UTI
UTI
XMTR
XMTR
Q4 25
$162.8M
$219.1M
Q3 25
$169.1M
$224.5M
Q2 25
$70.7M
$225.8M
Q1 25
$96.0M
$231.4M
Q4 24
$172.0M
$239.8M
Q3 24
$161.9M
$234.0M
Q2 24
$115.5M
$240.9M
Q1 24
$116.1M
$253.8M
Total Debt
UTI
UTI
XMTR
XMTR
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Q1 24
$141.9M
Stockholders' Equity
UTI
UTI
XMTR
XMTR
Q4 25
$335.9M
$275.6M
Q3 25
$328.1M
$272.0M
Q2 25
$306.8M
$270.4M
Q1 25
$293.9M
$309.9M
Q4 24
$280.0M
$314.5M
Q3 24
$260.2M
$315.2M
Q2 24
$239.4M
$315.8M
Q1 24
$232.6M
$320.4M
Total Assets
UTI
UTI
XMTR
XMTR
Q4 25
$834.0M
$703.7M
Q3 25
$826.1M
$698.9M
Q2 25
$740.8M
$687.0M
Q1 25
$720.4M
$690.1M
Q4 24
$753.8M
$680.1M
Q3 24
$744.6M
$678.2M
Q2 24
$706.0M
$678.6M
Q1 24
$702.1M
$692.5M
Debt / Equity
UTI
UTI
XMTR
XMTR
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×
Q1 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
UTI
UTI
XMTR
XMTR
Operating Cash FlowLast quarter
$3.1M
$4.4M
Free Cash FlowOCF − Capex
$-19.2M
$-5.9M
FCF MarginFCF / Revenue
-8.7%
-3.0%
Capex IntensityCapex / Revenue
10.1%
5.3%
Cash ConversionOCF / Net Profit
0.24×
TTM Free Cash FlowTrailing 4 quarters
$16.6M
$-24.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
UTI
UTI
XMTR
XMTR
Q4 25
$3.1M
$4.4M
Q3 25
$57.1M
$5.8M
Q2 25
$18.1M
$-427.0K
Q1 25
$-789.0K
$-3.7M
Q4 24
$23.0M
$9.1M
Q3 24
$67.5M
$-3.6M
Q2 24
$10.0M
$-9.1M
Q1 24
$-2.5M
$-11.7M
Free Cash Flow
UTI
UTI
XMTR
XMTR
Q4 25
$-19.2M
$-5.9M
Q3 25
$40.6M
$-1.7M
Q2 25
$6.8M
$-7.4M
Q1 25
$-11.7M
$-9.2M
Q4 24
$19.6M
$4.5M
Q3 24
$60.0M
$-8.4M
Q2 24
$3.0M
$-13.5M
Q1 24
$-8.4M
$-16.1M
FCF Margin
UTI
UTI
XMTR
XMTR
Q4 25
-8.7%
-3.0%
Q3 25
18.3%
-0.9%
Q2 25
3.4%
-4.5%
Q1 25
-5.7%
-6.1%
Q4 24
9.7%
3.1%
Q3 24
30.6%
-6.0%
Q2 24
1.7%
-10.2%
Q1 24
-4.6%
-13.1%
Capex Intensity
UTI
UTI
XMTR
XMTR
Q4 25
10.1%
5.3%
Q3 25
7.4%
4.1%
Q2 25
5.5%
4.3%
Q1 25
5.3%
3.6%
Q4 24
1.7%
3.1%
Q3 24
3.8%
3.4%
Q2 24
4.0%
3.3%
Q1 24
3.2%
3.5%
Cash Conversion
UTI
UTI
XMTR
XMTR
Q4 25
0.24×
Q3 25
3.04×
Q2 25
1.69×
Q1 25
-0.07×
Q4 24
1.04×
Q3 24
3.58×
Q2 24
2.01×
Q1 24
-0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

XMTR
XMTR

US$159.1M83%
Non Us$33.3M17%

Related Comparisons